JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
Other Operating Expenses
JW (Cayman) Therapeutics Co Ltd
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Other Operating Expenses
-¥28.8m
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Other Operating Expenses
¥233.1m
|
CAGR 3-Years
55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Other Operating Expenses
-¥66.9m
|
CAGR 3-Years
36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Other Operating Expenses
¥45.2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Other Operating Expenses
-¥21.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-14%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Other Operating Expenses
¥14.6m
|
CAGR 3-Years
73%
|
CAGR 5-Years
89%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Other Operating Expenses?
Other Operating Expenses
-28.8m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Other Operating Expenses amounts to -28.8m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
-69%
The average annual Other Operating Expenses growth rates for JW (Cayman) Therapeutics Co Ltd have been -69% over the past three years .